1. Allis, C. D. & Jenuwein, T. The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17, 487–500 (2016).

2. Bannister, A. J. & Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res. 21, 381–395 (2011).

3. Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K. & Schapira, M. Epigenetic protein families: a new frontier for drug discovery. Nat. Rev. Drug Discov. 11, 384–400 (2012).

4. Brown, P. J. & Müller, S. Open access chemical probes for epigenetic targets. Future Med. Chem. 7, 1901–1917 (2015).

5. Huston, A., Arrowsmith, C. H., Knapp, S. & Schapira, M. Probing the epigenome. Nat. Chem. Biol. 11, 542 (2015).

6. Yang, L., Rau, R. & Goodell, M. A. DNMT3A in haematological malignancies. Nat. Rev. Cancer 15, 152 (2015).

7. Vougiouklakis, T., Hamamoto, R., Nakamura, Y. & Saloura, V. The NSD family of protein methyltransferases in human cancer. Epigenomics 7, 863–874 (2015).

8. Kang, D. et al. The histone methyltransferase Wolf–Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis. Genes, Chromosome. Cancer 52, 126–139 (2013).

9. Angrand, P. O. et al. NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines. Genomics 74, 79–88 (2001).

10. Shen, C. et al. NSD3-short is an adaptor protein that couples BRD4 to the CHD8 chromatin remodeler. Mol. Cell 60, 847–859 (2015).

11. Gelsi-Boyer, V. et al. Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol. Cancer Res. 3, 655 (2005).

12. Wu, H. et al. Structural and histone binding ability characterizations of human PWWP domains. PLoS ONE 6, e18919 (2011).

13. Qin, S. & Min, J. Structure and function of the nucleosome-binding PWWP domain. Trends Biochem. Sci. 39, 536–547 (2014).

14. Vezzoli, A. et al. Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1. Nat. Struct. Mol. Biol. 17, 617–619 (2010).

15. Hubbard, R. E. Fragment approaches in structure-based drug discovery. J. Synchrotron Rad. 15, 227–230 (2008).

16. Baurin, N. et al. Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets. J. Chem. Inf. Comp. Sci. 44, 2157–2166 (2004).

17. Bergner, A. & Parel, S. P. Hit expansion approaches using multiple similarity methods and virtualized query structures. J. Chem. Inf. Modeling 53, 1057–1066 (2013).

18. Hosmane, R. S. & Liebman, J. F. Paradoxes and paradigms: why is quinoline less basic than pyridine or isoquinoline? A classical organic chemical perspective. Struct. Chem. 20, 693–697 (2009).

19. Fang, R. et al. Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. Mol. Cell 39, 222–233 (2010).

20. Machleidt, T. et al. NanoBRET—a novel BRET platform for the analysis of protein–protein interactions. ACS Chem. Bio. 10, 1797–1804 (2015).

21. Jafari, R. et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat. Protoc. 9, 2100–2122 (2014).

22. Dart, M. L. et al. Homogeneous assay for target engagement utilizing bioluminescent thermal shift. ACS Med. Chem. Lett. 9, 546–551 (2018).

23. Philpott, M. et al. Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching. Epigenetics & Chromatin 7, 14 (2014).

24. Frye, S. V. The art of the chemical probe. Nat. Chem. Biol. 6, 159–161 (2010).

25. Ross, A. & Senn, H. Automation of measurements and data evaluation in biomolecular NMR screening. Drug Discov. 6, 583–593 (2001).

26. Mayer, M. & Meyer, B. Characterization of ligand binding by saturation transfer difference NMR Spectroscopy. Angew. Chem. Int. Edn 38, 1784–1788 (1999).

27. Nietlispach, D. Suppression of anti-TROSY lines in a sensitivity enhanced gradient selection TROSY scheme. J. Biomol. NMR 31, 161–166 (2005).

28. Pervushin, K., Riek, R., Wider, G. & Wüthrich, K. Attenuated T(2) relaxation by mutual cancellation of dipole–dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl Acad. Sci. USA 94, 12366–12371 (1997).

29. Grzesiek, S., Stahl, S. J., Wingfield, P. T. & Bax, A. The CD4 determinant for downregulation by HIV-1 Nef Directly Binds to Nef. Mapping of the Nef Binding Surface by NMR. Biochem. 35, 10256–10261 (1996).

30. Peng, C., Unger, S. W., Filipp, F. V., Sattler, M. & Szalma, S. Automated evaluation of chemical shift perturbation spectra: new approaches to quantitative analysis of receptor-ligand interaction NMR spectra. J. Biomol. NMR 29, 491–504 (2004).

31. Martin, L. J. et al. Structure-sased design of an in vivo active selective BRD9 inhibitor. J. Med. Chem. 59, 4462–4475 (2016).

32. Willett, P. Combination of similarity rankings using data fusion. J. Chem. Inf. Mod. 53, 1–10 (2013).

33. Hert, J. et al. New methods for ligand-based virtual screening: use of data fusion and machine learning to enhance the effectiveness of similarity searching. J. Chem. Inf. Mod. 46, 462–470 (2006).

34. Hawkins, P. C. D., Skillman, A. G. & Nicholls, A. Comparison of shape-matching and docking as virtual screening tools. J. Med. Chem. 50, 74–82 (2007).

35. Cheeseright, T. J., Mackey, M. D., Melville, J. L. & Vinter, J. G. FieldScreen: virtual screening using molecular fields. Application to the DUD data set. J. Chem. Inf. Mod. 48, 2108–2117 (2008).

36. Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Prot. 13, 2513–2526 (2014).

37. Yu, W. et al. A scintillation proximity assay for histone demethylases. Anal. Biochem. 463, 54–60 (2014).

38. Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12–21 (2010).

39. Vonrhein, C. et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. D 67, 293–302 (2011).

40. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of COOT. Acta Crystallogr. D 66, 486–501 (2010).

41. Collaborative. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994).